Dashboard
High Management Efficiency with a high ROCE of 24.43%
Healthy long term growth as Net Sales has grown by an annual rate of 9.51%
The company has declared Positive results for the last 5 consecutive quarters
With ROCE of 30.38%, it has a fair valuation with a 4.57 Enterprise value to Capital Employed
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Booz Allen Hamilton Holding Corp. for the last several years.
Risk Adjusted Returns v/s 
News
Is Booz Allen Hamilton Holding Corp. overvalued or undervalued?
As of 24 October 2025, the valuation grade for Booz Allen Hamilton Holding Corp. has moved from very attractive to fair. The company appears to be overvalued based on its current valuation ratios, including a P/E ratio of 19, a Price to Book Value of 15.80, and an EV to EBITDA of 13.31. In comparison, peers such as ICON plc have a P/E of 14.64 and an EV to EBITDA of 10.21, suggesting that Booz Allen's valuation is relatively high within its industry. Additionally, Booz Allen's stock has underperformed against the S&P 500, with a year-to-date return of -28.98% compared to the S&P 500's 15.47%. This significant underperformance reinforces the notion that the stock may be overvalued at its current price of 91.40....
Read MoreIs Booz Allen Hamilton Holding Corp. overvalued or undervalued?
As of 24 October 2025, the valuation grade for Booz Allen Hamilton Holding Corp. has moved from very attractive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 19, an EV to EBITDA of 13.31, and a PEG ratio of 0.40, which suggests that the stock may not be significantly undervalued compared to its earnings growth potential. In comparison to peers, Booz Allen's P/E ratio of 19 is higher than ICON plc's 14.64 but lower than Charles River Laboratories' 27.84, indicating a mixed competitive positioning. Additionally, its EV to EBITDA ratio of 13.31 is more favorable than Charles River's 11.15, suggesting that it is more efficiently valued in terms of earnings before interest, taxes, depreciation, and amortization. The company's recent performance has lagged behind the S&P 500, with a year-to-date return of -28.98% compared to the index's 15.47%, r...
Read MoreIs Booz Allen Hamilton Holding Corp. overvalued or undervalued?
As of 24 October 2025, the valuation grade for Booz Allen Hamilton Holding Corp. has moved from very attractive to fair. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 19, a Price to Book Value of 15.80, and an EV to EBITDA of 13.31. In comparison, peers such as ICON plc have a lower P/E of 14.64, and Charles River Laboratories International, Inc. has a significantly higher P/E of 27.84, indicating that Booz Allen's valuation may not be justified relative to its peers. The company's stock has underperformed against the S&P 500, with a year-to-date return of -28.98% compared to the S&P 500's 15.47%, and a one-year return of -45.12% versus the S&P 500's 16.90%. This underperformance reinforces the notion that Booz Allen Hamilton Holding Corp. is currently overvalued....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 125 Schemes (40.73%)
Held by 352 Foreign Institutions (23.34%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is -1.70% vs 1.97% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 40.25% vs 3.17% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 12.36% vs 15.15% in Mar 2024
YoY Growth in year ended Mar 2025 is 54.74% vs 122.84% in Mar 2024






